News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
233 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4152)
February (4569)
March (4908)
April (4902)
May (5255)
June (4735)
July (4593)
August (4725)
September (5112)
October (5032)
November (5368)
December (4315)
Day
1 (5)
2 (305)
3 (298)
4 (217)
5 (233)
6 (147)
7 (5)
8 (2)
9 (236)
10 (272)
11 (253)
12 (267)
13 (130)
14 (5)
15 (14)
16 (219)
17 (216)
18 (216)
19 (181)
20 (159)
21 (10)
22 (15)
23 (179)
24 (237)
25 (208)
26 (209)
27 (139)
28 (19)
29 (10)
30 (258)
31 (244)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Biotech Beach
Scorpion Venom Could Improve Immuno-Oncology Therapies in Brain Cancer
Researchers with City of Hope have developed a chimeric antigen receptor (CAR) T cell therapy leveraging chlorotoxin, a component of scorpion venom.
March 5, 2020
·
3 min read
·
Mark Terry
Biotech Beach
Research Roundup: Cruise Ship Quarantine Data and More
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
March 5, 2020
·
4 min read
·
Mark Terry
Novartis Teams Up with Startup Orionis to Tackle Elusive Drug Targets
The two companies forged a collaboration to discover and design novel small molecule therapeutics, such as protein degraders, across various therapeutic areas
March 5, 2020
·
2 min read
·
Alex Keown
Drug Development
Coronavirus Update: Vaccines Rushing into Clinical Trials
As the coronavirus outbreak that causes COVID-19 escalates, biopharma companies and government agents are working quickly to develop and test a vaccine, although most estimates are it will take 12 to 18 months before it could get to market.
March 5, 2020
·
7 min read
·
Mark Terry
Business
Fred Hutchinson Implements Remote Work Policies During Coronavirus Outbreak
The mandatory work-from-home policy will remain in effect through March 31, but could be extended depending on circumstances.
March 5, 2020
·
1 min read
·
Alex Keown
Career Advice
Demystifying Job Interview Questions: ‘What Are Your Career Goals?’
Questions about the future are not uncommon in job interviews and represent an opportunity for careful preparation.
March 5, 2020
·
3 min read
·
Katharine Hansen, PhD
Pharma More Profitable than Other Large Industries, Study Shows
A new study indicates that the profits gained by drug developers outpaced those of other publicly-traded companies by a wide margin over an 18-year period.
March 5, 2020
·
2 min read
·
Alex Keown
Bio NC
Coronavirus Stimulates Biopharma and Academia Research Activities and Collaborations
Biopharma companies, government regulatory and health agencies and academic centers are stepping forward and working to test or develop vaccines and therapeutics for the disease.
March 5, 2020
·
7 min read
·
Mark Terry
BioMidwest
Researchers Develop New Compound to Battle Drug-Resistant Superbugs
The compound has been licensed to Arch Biopartners and is currently in Phase I clinical trials.
March 5, 2020
·
3 min read
·
Mark Terry
Business
BioSpace Movers & Shakers, March 6
Life sciences and pharma companies from across the globe strengthen their leadership teams and board with this week’s Movers & Shakers.
March 5, 2020
·
5 min read
·
Alex Keown
1 of 24
Next